Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study.

Dini S, Douglas NM, Poespoprodjo JR, Kenangalem E, Sugiarto P, Plumb ID, Price RN, Simpson JA.

BMC Med. 2020 Feb 20;18(1):28. doi: 10.1186/s12916-020-1497-0.

2.

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study.

Douglas NM, Kenangalem E, Hasanuddin A, Anstey NM, Sugiarto P, Price RN, Poespoprodjo JR.

PLoS One. 2020 Jan 29;15(1):e0228018. doi: 10.1371/journal.pone.0228018. eCollection 2020.

3.

Intravenous artesunate plus oral dihydroartemisinin-piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia.

Sikora SA, Poespoprodjo JR, Kenangalem E, Lampah DA, Sugiarto P, Laksono IS, Ahmad RA, Murhandarwati EEH.

Malar J. 2019 Dec 30;18(1):448. doi: 10.1186/s12936-019-3085-3.

4.

Early and late mortality after malaria in young children in Papua, Indonesia.

Patriani D, Arguni E, Kenangalem E, Dini S, Sugiarto P, Hasanuddin A, Lampah DA, Douglas NM, Anstey NM, Simpson JA, Price RN, Poespoprodjo JR.

BMC Infect Dis. 2019 Oct 30;19(1):922. doi: 10.1186/s12879-019-4497-y.

5.

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study.

Kenangalem E, Poespoprodjo JR, Douglas NM, Burdam FH, Gdeumana K, Chalfein F, Prayoga, Thio F, Devine A, Marfurt J, Waramori G, Yeung S, Noviyanti R, Penttinen P, Bangs MJ, Sugiarto P, Simpson JA, Soenarto Y, Anstey NM, Price RN.

PLoS Med. 2019 May 29;16(5):e1002815. doi: 10.1371/journal.pmed.1002815. eCollection 2019 May.

6.

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia.

Setyadi A, Arguni E, Kenangalem E, Hasanuddin A, Lampah DA, Thriemer K, Anstey NM, Sugiarto P, Simpson JA, Price RN, Douglas NM, Poespoprodjo JR.

Malar J. 2019 Apr 2;18(1):111. doi: 10.1186/s12936-019-2745-7.

7.

Bridging the knowledge-practice gap in tuberculosis contact management in a high-burden setting: a mixed-methods protocol for a multicenter health system strengthening study.

Lestari T, Graham S, van den Boogard C, Triasih R, Poespoprodjo JR, Ubra RR, Kenangalem E, Mahendradhata Y, Anstey NM, Bailie RS, Ralph AP.

Implement Sci. 2019 Mar 19;14(1):31. doi: 10.1186/s13012-019-0870-x.

8.

Glycocalyx Breakdown Is Associated With Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.

Yeo TW, Weinberg JB, Lampah DA, Kenangalem E, Bush P, Chen Y, Price RN, Young S, Zhang HY, Millington D, Granger DL, Anstey NM.

Clin Infect Dis. 2019 Oct 30;69(10):1712-1720. doi: 10.1093/cid/ciz038.

9.

Circulating Neutrophil Extracellular Traps and Neutrophil Activation Are Increased in Proportion to Disease Severity in Human Malaria.

Kho S, Minigo G, Andries B, Leonardo L, Prayoga P, Poespoprodjo JR, Kenangalem E, Price RN, Woodberry T, Anstey NM, Yeo TW.

J Infect Dis. 2019 May 24;219(12):1994-2004. doi: 10.1093/infdis/jiy661. Erratum in: J Infect Dis. 2019 May 24;219(12):2026.

10.

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia.

Oyong DA, Kenangalem E, Poespoprodjo JR, Beeson JG, Anstey NM, Price RN, Boyle MJ.

JCI Insight. 2018 Nov 15;3(22). pii: 124854. doi: 10.1172/jci.insight.124854.

11.

Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.

Loughland JR, Woodberry T, Boyle MJ, Tipping PE, Piera KA, Amante FH, Kenangalem E, Price RN, Engwerda CR, Anstey NM, McCarthy JS, Minigo G.

J Infect Dis. 2019 Jan 29;219(4):660-671. doi: 10.1093/infdis/jiy555.

12.

Platelets kill circulating parasites of all major Plasmodium species in human malaria.

Kho S, Barber BE, Johar E, Andries B, Poespoprodjo JR, Kenangalem E, Piera KA, Ehmann A, Price RN, William T, Woodberry T, Foote S, Minigo G, Yeo TW, Grigg MJ, Anstey NM, McMorran BJ.

Blood. 2018 Sep 20;132(12):1332-1344. doi: 10.1182/blood-2018-05-849307. Epub 2018 Jul 19.

13.

Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.

Thriemer K, Bobogare A, Ley B, Gudo CS, Alam MS, Anstey NM, Ashley E, Baird JK, Gryseels C, Jambert E, Lacerda M, Laihad F, Marfurt J, Pasaribu AP, Poespoprodjo JR, Sutanto I, Taylor WR, van den Boogaard C, Battle KE, Dysoley L, Ghimire P, Hawley B, Hwang J, Khan WA, Mudin RNB, Sumiwi ME, Ahmed R, Aktaruzzaman MM, Awasthi KR, Bardaji A, Bell D, Boaz L, Burdam FH, Chandramohan D, Cheng Q, Chindawongsa K, Culpepper J, Das S, Deray R, Desai M, Domingo G, Duoquan W, Duparc S, Floranita R, Gerth-Guyette E, Howes RE, Hugo C, Jagoe G, Sariwati E, Jhora ST, Jinwei W, Karunajeewa H, Kenangalem E, Lal BK, Landuwulang C, Le Perru E, Lee SE, Makita LS, McCarthy J, Mekuria A, Mishra N, Naket E, Nambanya S, Nausien J, Duc TN, Thi TN, Noviyanti R, Pfeffer D, Qi G, Rahmalia A, Rogerson S, Samad I, Sattabongkot J, Satyagraha A, Shanks D, Sharma SN, Sibley CH, Sungkar A, Syafruddin D, Talukdar A, Tarning J, Ter Kuile F, Thapa S, Theodora M, Huy TT, Waramin E, Waramori G, Woyessa A, Wongsrichanalai C, Xa NX, Yeom JS, Hermawan L, Devine A, Nowak S, Jaya I, Supargiyono S, Grietens KP, Price RN.

Malar J. 2018 Jun 20;17(1):241. doi: 10.1186/s12936-018-2380-8.

14.

High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia.

Kho S, Andries B, Poespoprodjo JR, Commons RJ, Shanti PAI, Kenangalem E, Douglas NM, Simpson JA, Sugiarto P, Anstey NM, Price RN.

Clin Infect Dis. 2019 Jan 1;68(1):51-60. doi: 10.1093/cid/ciy403.

15.

Therapeutic Response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia.

Poespoprodjo JR, Kenangalem E, Wafom J, Chandrawati F, Puspitasari AM, Ley B, Trianty L, Korten Z, Surya A, Syafruddin D, Anstey NM, Marfurt J, Noviyanti R, Price RN.

Am J Trop Med Hyg. 2018 Mar;98(3):677-682. doi: 10.4269/ajtmh.17-0662. Epub 2018 Jan 11.

16.

Treatment-Seeking Behavior after the Implementation of a Unified Policy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Papua, Indonesia.

Devine A, Kenangalem E, Burdam FH, Anstey NM, Poespoprodjo JR, Price RN, Yeung S.

Am J Trop Med Hyg. 2018 Feb;98(2):543-550. doi: 10.4269/ajtmh.17-0680. Epub 2017 Dec 21.

17.

Passively versus Actively Detected Malaria: Similar Genetic Diversity but Different Complexity of Infection.

Pava Z, Handayuni I, Trianty L, Utami RAS, Tirta YK, Puspitasari AM, Burdam F, Kenangalem E, Wirjanata G, Kho S, Trimarsanto H, Anstey N, Poespoprodjo JR, Noviyanti R, Price RN, Marfurt J, Auburn S.

Am J Trop Med Hyg. 2017 Dec;97(6):1788-1796. doi: 10.4269/ajtmh.17-0364. Epub 2017 Aug 31.

18.

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.

Douglas NM, Poespoprodjo JR, Patriani D, Malloy MJ, Kenangalem E, Sugiarto P, Simpson JA, Soenarto Y, Anstey NM, Price RN.

PLoS Med. 2017 Aug 29;14(8):e1002379. doi: 10.1371/journal.pmed.1002379. eCollection 2017 Aug.

19.

Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.

Wirjanata G, Handayuni I, Prayoga P, Leonardo L, Apriyanti D, Trianty L, Wandosa R, Gobay B, Kenangalem E, Poespoprodjo JR, Noviyanti R, Kyle DE, Cheng Q, Price RN, Marfurt J.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00355-17. doi: 10.1128/AAC.00355-17. Print 2017 Aug.

20.

Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infections.

Pava Z, Noviyanti R, Handayuni I, Trimarsanto H, Trianty L, Burdam FH, Kenangalem E, Utami RAS, Tirta YK, Coutrier F, Poespoprodjo JR, Price RN, Marfurt J, Auburn S.

PLoS One. 2017 May 12;12(5):e0177445. doi: 10.1371/journal.pone.0177445. eCollection 2017.

21.

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.

Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, Sattabongkot J, Jambert E, Domingo GJ, Commons R, Auburn S, Marfurt J, Devine A, Aktaruzzaman MM, Sohel N, Namgay R, Drukpa T, Sharma SN, Sarawati E, Samad I, Theodora M, Nambanya S, Ounekham S, Mudin RN, Da Thakur G, Makita LS, Deray R, Lee SE, Boaz L, Danansuriya MN, Mudiyanselage SD, Chinanonwait N, Kitchakarn S, Nausien J, Naket E, Duc TN, Do Manh H, Hong YS, Cheng Q, Richards JS, Kusriastuti R, Satyagraha A, Noviyanti R, Ding XC, Khan WA, Swe Phru C, Guoding Z, Qi G, Kaneko A, Miotto O, Nguitragool W, Roobsoong W, Battle K, Howes RE, Roca-Feltrer A, Duparc S, Bhowmick IP, Kenangalem E, Bibit JA, Barry A, Sintasath D, Abeyasinghe R, Sibley CH, McCarthy J, von Seidlein L, Baird JK, Price RN.

Malar J. 2017 Apr 5;16(1):141. doi: 10.1186/s12936-017-1784-1. Review.

22.

Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia.

Karyana M, Devine A, Kenangalem E, Burdarm L, Poespoprodjo JR, Vemuri R, Anstey NM, Tjitra E, Price RN, Yeung S.

Malar J. 2016 Nov 8;15(1):536.

23.

Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia.

Pava Z, Burdam FH, Handayuni I, Trianty L, Utami RA, Tirta YK, Kenangalem E, Lampah D, Kusuma A, Wirjanata G, Kho S, Simpson JA, Auburn S, Douglas NM, Noviyanti R, Anstey NM, Poespoprodjo JR, Marfurt J, Price RN.

PLoS One. 2016 Oct 27;11(10):e0165340. doi: 10.1371/journal.pone.0165340. eCollection 2016.

24.

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life.

Burdam FH, Hakimi M, Thio F, Kenangalem E, Indrawanti R, Noviyanti R, Trianty L, Marfurt J, Handayuni I, Soenarto Y, Douglas NM, Anstey NM, Price RN, Poespoprodjo JR.

PLoS One. 2016 Aug 9;11(8):e0160917. doi: 10.1371/journal.pone.0160917. eCollection 2016.

25.

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.

Kho S, Marfurt J, Handayuni I, Pava Z, Noviyanti R, Kusuma A, Piera KA, Burdam FH, Kenangalem E, Lampah DA, Engwerda CR, Poespoprodjo JR, Price RN, Anstey NM, Minigo G, Woodberry T.

Malar J. 2016 Jun 21;15:328. doi: 10.1186/s12936-016-1382-7.

26.

Plasmodium vivax infection: a major determinant of severe anaemia in infancy.

Kenangalem E, Karyana M, Burdarm L, Yeung S, Simpson JA, Tjitra E, Anstey NM, Poespoprodjo JR, Price RN, Douglas NM.

Malar J. 2016 Jun 16;15:321. doi: 10.1186/s12936-016-1373-8.

27.

Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms.

Wirjanata G, Handayuni I, Zaloumis SG, Chalfein F, Prayoga P, Kenangalem E, Poespoprodjo JR, Noviyanti R, Simpson JA, Price RN, Marfurt J.

Malar J. 2016 Mar 2;15:137. doi: 10.1186/s12936-016-1173-1.

28.

Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study.

Langford S, Douglas NM, Lampah DA, Simpson JA, Kenangalem E, Sugiarto P, Anstey NM, Poespoprodjo JR, Price RN.

PLoS Negl Trop Dis. 2015 Dec 31;9(12):e0004195. doi: 10.1371/journal.pntd.0004195. eCollection 2015 Dec.

29.

Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.

Wirjanata G, Handayuni I, Prayoga P, Apriyanti D, Chalfein F, Sebayang BF, Kho S, Noviyanti R, Kenangalem E, Campo B, Poespoprodjo JR, Price RN, Marfurt J.

Malar J. 2015 Oct 24;14:417. doi: 10.1186/s12936-015-0940-8.

30.

Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.

Wirjanata G, Sebayang BF, Chalfein F, Prayoga, Handayuni I, Trianty L, Kenangalem E, Noviyanti R, Campo B, Poespoprodjo JR, Möhrle JJ, Price RN, Marfurt J.

Antimicrob Agents Chemother. 2015 Oct;59(10):6117-24. doi: 10.1128/AAC.00874-15. Epub 2015 Jul 20.

31.

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Sugiarto P, Tjitra E, Anstey NM, Price RN.

Malar J. 2015 Jul 15;14:272. doi: 10.1186/s12936-015-0794-0.

32.

Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.

Wirjanata G, Sebayang BF, Chalfein F, Prayoga, Handayuni I, Noviyanti R, Kenangalem E, Poespoprodjo JR, Burgess SJ, Peyton DH, Price RN, Marfurt J.

Antimicrob Agents Chemother. 2015 Sep;59(9):5721-6. doi: 10.1128/AAC.01048-15. Epub 2015 Jul 6.

33.

Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.

Kho S, Marfurt J, Noviyanti R, Kusuma A, Piera KA, Burdam FH, Kenangalem E, Lampah DA, Engwerda CR, Poespoprodjo JR, Price RN, Anstey NM, Minigo G, Woodberry T.

Infect Immun. 2015 Aug;83(8):3224-32. doi: 10.1128/IAI.00226-15. Epub 2015 Jun 1.

34.

Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Price RN, Weinberg JB, Hyland K, Granger DL, Anstey NM.

PLoS Pathog. 2015 Mar 12;11(3):e1004667. doi: 10.1371/journal.ppat.1004667. eCollection 2015 Mar.

35.

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.

Douglas NM, Pontororing GJ, Lampah DA, Yeo TW, Kenangalem E, Poespoprodjo JR, Ralph AP, Bangs MJ, Sugiarto P, Anstey NM, Price RN.

BMC Med. 2014 Nov 18;12:217. doi: 10.1186/s12916-014-0217-z.

36.

Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia.

Lampah DA, Yeo TW, Malloy M, Kenangalem E, Douglas NM, Ronaldo D, Sugiarto P, Simpson JA, Poespoprodjo JR, Anstey NM, Price RN.

J Infect Dis. 2015 Feb 15;211(4):623-34. doi: 10.1093/infdis/jiu487. Epub 2014 Aug 28.

37.

Decreased endothelial nitric oxide bioavailability, impaired microvascular function, and increased tissue oxygen consumption in children with falciparum malaria.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Weinberg JB, Granger DL, Price RN, Anstey NM.

J Infect Dis. 2014 Nov 15;210(10):1627-32. doi: 10.1093/infdis/jiu308. Epub 2014 May 30.

38.

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Sugiarto P, Tjitra E, Anstey NM, Price RN.

PLoS One. 2014 Jan 17;9(1):e84976. doi: 10.1371/journal.pone.0084976. eCollection 2014.

39.

Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.

Douglas NM, Lampah DA, Kenangalem E, Simpson JA, Poespoprodjo JR, Sugiarto P, Anstey NM, Price RN.

PLoS Med. 2013 Dec;10(12):e1001575; discussion e1001575. doi: 10.1371/journal.pmed.1001575. Epub 2013 Dec 17.

40.

High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena.

Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire GP, Kelly PM, Anstey NM.

PLoS One. 2013 Nov 29;8(11):e80302. doi: 10.1371/journal.pone.0080302. eCollection 2013.

41.

Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between papuan and non-Papuan ethnic groups.

Kenangalem E, Waramori G, Pontororing GJ, Sandjaja, Tjitra E, Maguire G, Kelly PM, Anstey NM, Ralph AP.

PLoS One. 2013 Sep 27;8(9):e76077. doi: 10.1371/journal.pone.0076077. eCollection 2013.

42.

L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.

Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E, Sandjaja, Lolong DB, Yeo TW, Chatfield MD, Soemanto RK, Bastian I, Lumb R, Maguire GP, Eisman J, Price RN, Morris PS, Kelly PM, Anstey NM.

PLoS One. 2013 Aug 14;8(8):e70032. doi: 10.1371/journal.pone.0070032. eCollection 2013.

43.

A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics.

Yeo TW, Lampah DA, Rooslamiati I, Gitawati R, Tjitra E, Kenangalem E, Price RN, Duffull SB, Anstey NM.

PLoS One. 2013 Jul 29;8(7):e69587. doi: 10.1371/journal.pone.0069587. Print 2013.

44.

Increased carboxyhemoglobin in adult falciparum malaria is associated with disease severity and mortality.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Price RN, Anstey NM.

J Infect Dis. 2013 Sep 1;208(5):813-7. doi: 10.1093/infdis/jit253. Epub 2013 Jul 12.

45.

Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria.

Pinzon-Charry A, Woodberry T, Kienzle V, McPhun V, Minigo G, Lampah DA, Kenangalem E, Engwerda C, López JA, Anstey NM, Good MF.

J Exp Med. 2013 Jul 29;210(8):1635-46. doi: 10.1084/jem.20121972. Epub 2013 Jul 8.

46.

Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.

Douglas NM, Simpson JA, Phyo AP, Siswantoro H, Hasugian AR, Kenangalem E, Poespoprodjo JR, Singhasivanon P, Anstey NM, White NJ, Tjitra E, Nosten F, Price RN.

J Infect Dis. 2013 Sep 1;208(5):801-12. doi: 10.1093/infdis/jit261. Epub 2013 Jun 12.

47.

Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment.

Ralph AP, Yeo TW, Salome CM, Waramori G, Pontororing GJ, Kenangalem E, Sandjaja, Tjitra E, Lumb R, Maguire GP, Price RN, Chatfield MD, Kelly PM, Anstey NM.

J Infect Dis. 2013 Aug 15;208(4):616-26. doi: 10.1093/infdis/jit248. Epub 2013 Jun 3.

48.

Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencing.

Auburn S, Marfurt J, Maslen G, Campino S, Ruano Rubio V, Manske M, Machunter B, Kenangalem E, Noviyanti R, Trianty L, Sebayang B, Wirjanata G, Sriprawat K, Alcock D, Macinnis B, Miotto O, Clark TG, Russell B, Anstey NM, Nosten F, Kwiatkowski DP, Price RN.

PLoS One. 2013;8(1):e53160. doi: 10.1371/journal.pone.0053160. Epub 2013 Jan 4.

49.

Impaired skeletal muscle microvascular function and increased skeletal muscle oxygen consumption in severe falciparum malaria.

Yeo TW, Lampah DA, Kenangalem E, Tjitra E, Price RN, Anstey NM.

J Infect Dis. 2013 Feb 1;207(3):528-36. doi: 10.1093/infdis/jis692. Epub 2012 Nov 16.

50.

An analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testing.

Kerlin DH, Boyce K, Marfurt J, Simpson JA, Kenangalem E, Cheng Q, Price RN, Gatton ML.

PLoS Negl Trop Dis. 2012;6(8):e1772. doi: 10.1371/journal.pntd.0001772. Epub 2012 Aug 7.

Supplemental Content

Loading ...
Support Center